accountGeneric versions of expensive biotechnology drugs would reduce the amount of money spent on health care in the United States, a Federal Trade Commission report said on Thursday.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to FTC: 12-14 yrs too long to protect biotech drugs
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account